40 mg famotidine pill identifier

If you are a consumer or patient please visit this version. Famotidine is a histamine-2 H 2 receptor antagonist indicated 1 :. Administration 2.

The active ingredient in famotidine tablets USP is a histamine H 2 -receptor antagonist. Famotidine, USP is [1-Amino[[[2-[ diaminomethylene amino]thiazolyl]methyl]thio] propylidene] sulfamide and has the following structural formula:. Famotidine, USP is a white to pale yellow crystalline compound that is freely soluble in glacial acetic acid, slightly soluble in methanol, very slightly soluble in water, and practically insoluble in ethanol. Each tablet for oral administration contains either 20 mg or 40 mg of famotidine, USP and has the following inactive ingredients: colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized corn starch, sodium starch glycolate, talc, titanium dioxide, yellow iron oxide. Famotidine is a competitive inhibitor of histamine H 2 -receptors. The primary clinically important pharmacologic activity of famotidine is inhibition of gastric secretion. Both the acid concentration and volume of gastric secretion are suppressed by famotidine, while changes in pepsin secretion are proportional to volume output.

40 mg famotidine pill identifier

.

Elimination Metabolism Famotidine undergoes minimal first-pass metabolism. Its structural formula is:. As shown in Table 6, patients treated with famotidine 20 mg twice daily had greater improvement in symptomatic GERD than patients treated with 40 mg at bedtime or placebo.

.

Famotidine tablets is a histamine-2 H 2 receptor antagonist indicated 1 :. Adult and Pediatric Patients. Administration 2. History of serious hypersensitivity reactions e. The most common adverse reactions are: headache, dizziness, constipation, and diarrhea. Famotidine tablets are indicated in adult and pediatric patients 40 kg and greater for the treatment of:.

40 mg famotidine pill identifier

Famotidine is used to treat stomach ulcers gastric and duodenal , erosive esophagitis heartburn or acid indigestion , and gastroesophageal reflux disease GERD. GERD is a condition where the acid in the stomach washes back up into the esophagus. It is also used to treat certain conditions where there is too much acid in the stomach eg, Zollinger-Ellison syndrome, multiple endocrine neoplasia. Famotidine belongs to the group of medicines known as histamine H2-receptor antagonists or H2-blockers.

Travelodge by wyndham las vegas

Patients not healed by week 4 were continued in the study. Controlled trials have not extended beyond one year. Trials have not assessed the safety of famotidine in uncomplicated active DU for periods of more than 8 weeks. Plasma levels after multiple doses are similar to those after single doses. Inactive Ingredients. In some patients, a higher starting dose may be required. Both the acid concentration and volume of gastric secretion are suppressed by famotidine, while changes in pepsin secretion are proportional to volume output. Special Senses Tinnitus, taste disorder. Famotidine tablets may be taken with or without food [see Clinical Pharmacology The same doses given in the morning suppressed food-stimulated acid secretion in all subjects.

.

Marketing Information. In this study, time to relief of daytime and nocturnal pain was shorter for patients receiving famotidine than for patients receiving placebo; patients receiving famotidine also took less antacid than patients receiving placebo. Two randomized, double-blind, multicenter trials in patients with endoscopically confirmed healed DUs demonstrated that patients receiving treatment with orally administered famotidine 20 mg at bedtime had lower rates of DU recurrence, as compared with placebo. In this study, time to relief of daytime and nocturnal pain was significantly shorter for patients receiving famotidine than for patients receiving placebo; patients receiving famotidine also took less antacid than the patients receiving placebo. Adult and Pediatric Patients 40 kg and greater. Anaphylaxis, angioedema, orbital or facial edema, urticaria, rash, conjunctival injection. CNS adverse reactions and prolonged QT intervals have been reported in patients with moderate and severe renal impairment [see Warnings and Precautions 5. For pediatric patients weighing less than 40 kg, consider another famotidine formulation e. Famotidine is a competitive inhibitor of histamine-2 H 2 receptors. Gastric emptying and exocrine pancreatic function were not affected by famotidine. The adverse reactions listed below have been reported during domestic and international clinical trials in approximately patients.